The FDA Has Issued A Recall For Zantac | SMT Legal

The FDA Has Issued A Recall For Zantac

Date: Apr 3rd, 2020 By Jonathan M. Stewart
Category: Zantac cancer

Six months after many major pharmacies took Zantac off of their shelves, federal regulators have now weighed in on the proper course of action concerning this drug and other ranitidine products. The US Food and Drug Administration (FDA) has asked that manufacturers of Zantac and the generic equivalent immediately pull all medications off the shelves. At SMT Legal, our Zantac cancer attorneys in Pittsburgh want to discuss what this means for the product and what victims can do if they think their cancer was caused by Zantac.

What This Recent Zantac Recall Means For Consumers

It is rare that the FDA steps in and asks for the complete removal of medication from the market. However, on April 1, 2020, The FDA asked manufacturers of Zantac and other ranitidine medications to remove all available prescription and over-the-counter versions of the drugs.

As of this announcement, ranitidine products will no longer be available for new or existing prescriptions over-the-counter use in the United States.

The FDA began looking into Zantac and other ranitidine products last year after third-party laboratories discovered abnormally high amounts of N-nitrosodimethylamine (NDMA) in the product. NDMA has been classified as a cancer-causing carcinogen for humans by the FDA, the US Environmental Protection Agency (EPA), and the World Health Organization (WHO).

The FDA says that NDMA is safe for humans at levels of 96 nanograms (ng) or less per day. However, testing has discovered that Zantac 150 mg tablets could contain as much as 2,500,000 ng of NDMA, far exceeding the allowable daily limits safe for human consumption.

To be sure, this FDA recall request was preceded by many major pharmaceutical companies pulling Zantac and other ranitidine products from their shelves last year. This recall adds validity to the many lawsuits that have been made against Zantac by consumers claiming that their cancer was caused by this product.

The FDA has requested that anybody who has Zantac or other ranitidine products at home stop using them immediately and properly dispose of them. Due to the ongoing COVID-19 pandemic, the FDA is asking that consumers do not take their medications to a drug take-back location, but that they follow drug disposal instructions for at-home disposal.

If you are affected by this new Zantac FDA recall, speak to your health care provider about what alternative medications there are for your conditions.

We will Help You Get Through This

If you or somebody you care about has been diagnosed with cancer and you believe Zantac caused the illness, seek legal assistance immediately. At SMT Legal, our product liability team will thoroughly investigate your case in order to secure any compensation you are entitled to. This could include:

  • Any current and future medical bills related to the cancer
  • Recovery of income and if you are unable to work
  • Pain and suffering damages
  • Loss of enjoyment of life damages
  • Possible punitive damages against Zantac’s manufacturer, Sanofi

If you need a Pittsburgh Zantac cancer attorney, you can contact us for a free consultation by clicking here or calling 412-765-3345.

For a free case evaluation
call : 412-765-3345